Sun Pharma Advanced Research Company informs about press release

14 May 2021 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it has enclosed the Press Release on 14th May 2021 titled ‘SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of PDP-716 for the Treatment of Open Angle Glaucoma or Ocular Hypertension’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

124.30 0.25 (0.20%)
06-Mar-2026 12:35 View Price Chart
Peers
Company Name CMP
Syngene Internation. 398.40
Indegene 462.55
CMS Info Systems 303.20
JITF Infralogistics 357.75
Sagility 39.52
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×